Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950137-97-001328
Filing Date
1997-03-31
Accepted
1997-03-31 00:00:00
Documents
4
Period of Report
1996-12-31
SROs
AMEX

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 133169
2 STOCK OPTION AGREEMENT EX-10.11 17315
3 EARNINGS PER SHARE EX-11.1 985
4 FDS EX-27 2057
  Complete submission text file 0000950137-97-001328.txt   155299
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 225 EAST DEERPATH STE 250 LAKE FOREST IL 60045 7082958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12493 | Film No.: 97569309
SIC: 8731 Services-Commercial Physical & Biological Research